XML 17 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:    
Net loss $ (809,890) $ (322,035)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Gain on sale of property, plant and equipment (21,554)  
Depreciation and amortization 803,217 745,440
Non-cash interest expense 16,753 13,842
Changes in allowance for doubtful accounts 12,000 (30,000)
Share-based compensation expense 32,417 30,591
Changes in operating assets and liabilities:    
Accounts receivable (1,176,664) 106,330
Insurance receivable   (258,842)
Inventories (194,180) (554,983)
Prepaid expenses and other current assets 4,159 36,855
Other non-current assets 145,603 52,602
Accounts payable 866,811 185,567
Accrued expenses and other current liabilities 117,361 83,922
Customer deposits 88,175 298,627
Deferred revenue, current (51,266) (19,156)
Other non-current liabilities (156,953) (29,510)
Net cash provided by (used in) operating activities (324,011) 339,250
Cash flows from investing activities:    
Purchases of property, plant and equipment (759,546) (960,144)
Proceeds from sale of property, plant and equipment 23,200  
Cash paid for patents and trademarks (15,296)  
Net cash provided by (used in) investing activities (751,642) (960,144)
Cash flows from financing activities:    
Proceeds from (payments on) revolving line of credit, net 884,205 570,000
Proceeds from equipment line of credit 402,281 544,851
Payments on term notes payable (253,145) (291,104)
Proceeds from stock option exercises   51,150
Net cash provided by (used in) financing activities 1,033,341 874,897
Net increase (decrease) in cash and cash equivalents (42,312) 254,003
Cash and cash equivalents, beginning of period 380,381 272,291
Cash and cash equivalents, end of period 338,069 526,294
Supplemental Cash Flow Information    
Cash paid for interest 138,279 113,112
Non-cash activities:    
Issuance of Treasury Stock for Directors Fees $ 11,250  
Equipment line of credit converted to term notes payable   $ 881,701